Amanda Eldridge

Amanda Eldridge is a Principal Scientist at Boston Scientific, specializing in Interventional Oncology with a focus on Recurrent Glioblastoma since July 2021. Previously, Amanda worked at Medtronic for over five years, starting as an Associate Manufacturing Engineer, where involvement included manufacturing arterial and deep venous stents and directional atherectomy systems, and then advancing to Senior Emerging Technologies Engineer in Peripheral Vascular Health, focusing on peripheral embolization therapies and emerging technologies. Amanda holds a Bachelor of Science degree in Mechanical and Biomedical Engineering from McGill University, earned between 2009 and 2015.